
Isodiol International Inc.
ISOLFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4914
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Isodiol International Inc.(ISOLF)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · ISOLF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2019-03 | 2018-03 | 2017-03 | 2016-03 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $16.65M | $14.84M | $0.27M | $0.01M |
| Cost of Revenue | $20.71M | $16.74M | $0.17M | $0.00M |
| Gross Profit | ($4.05M) | ($1.90M) | $0.10M | $0.01M |
| Gross Margin %(computed) | -24.35% | -12.80% | 35.60% | 61.83% |
| Operating Expenses | ||||
| R&D Expenses | $0.08M | $0.47M | $0.10M | $0.00M |
| G&A Expenses | $16.56M | $11.89M | $1.84M | $0.00M |
| Total Operating Expenses | $25.17M | $16.18M | $2.68M | $1.92M |
| Operating Income | ($29.23M) | ($18.08M) | ($2.59M) | ($1.91M) |
| Operating Margin %(computed) | -175.52% | -121.79% | -970.06% | — |
| Interest Income | ($0.00M) | $0.00M | $0.00M | $0.00M |
| Interest Expense | $4.47M | $0.00M | $0.07M | $0.06M |
| Income Before Tax | ($90.51M) | ($27.71M) | ($3.21M) | ($6.71M) |
| Income Tax Expense | ($0.23M) | $0.23M | ($0.02M) | $0.00M |
| Net Income | ($90.28M) | ($27.94M) | ($3.21M) | ($6.71M) |
| Net Margin %(computed) | -542.13% | -188.22% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-2.35 | $-1.33 | $-1.01 | $-4.53 |
| Wtd Avg Shares | 38.40M | 20.94M | 3.18M | 1.48M |
| EBITDA | ($84.50M) | ($26.85M) | ($2.59M) | ($6.65M) |
| EBITDA Margin %(computed) | -507.37% | -180.90% | -970.06% | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M
深入了解Isodiol International Inc.
关于Isodiol International Inc.(ISOLF)损益表
Isodiol International Inc.(ISOLF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2019财年,ISOLF实现营收$0.02B,毛利润($0.00B)(毛利率-24.35%),净利润($0.09B)(净利率-542.13%)。
常见问题
ISOLF · 4 问Isodiol International Inc.(ISOLF)2019财年营收为$0.02B,同比up12.2%。
ISOLF revenueISOLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09